$QQQ $SP
All of those things have been set up for over a year now. And according to some on here, some of those things have been set up for even way longer than that.
If those thingd you listed were going to crash the market, it would done so already.
Or, maybe the pull-backs we’ve already had over the last year or two WERE the correction caused by those things.
No, those things have already been in place for more than a year now. The only thing that will cause the next correction/bear market is going to have to be something new.
$QQQ $SP $TSLA $NVDA The odds of SpaceX $SPCX closing above $200 by end of July on Polymarket currently sit at 40%.
The odds of it closing above $210 sit at 19%.🤔🤔
$INTC INTC $100-$98 could happen in the blink of an eye. 📉
7/8/2026
Oil is spiking as the market appears to be pricing in the risk that the Strait of Hormuz remains closed and there are still no serious U.S.-Iran talks.
Higher energy prices could add pressure to tech and semis.
$QQQ $USO $MU $SP
$CORT CORT is easily a "MC=$25B to$30B" or "SP=$250 to $300" company, why?
- Korlym/CS is generating $900M to $1B a year with authorized generic taking into account, which pays for all the bills, R&D and clinical trials;
- Lifyorli/PROC (selling for $150K to $250K/prescription/year) will reach $1B peak sales in 2028-2029, which will contribute $4B to $5B to MC;
Relacorilant/CS will be approved in 2026 and reach $2B peak sales in 2028-2029, which will contribute $8B to $10B to MC;
- Dazucorilant/ALS P3 trial will be started in Q4/2026, approved in 2027-2028, selling for $150K to $250K/prescription/year, and reach $1B peak sales in 2029-2030, which will contribute $4B to $5B to MC;
- Miricorilant/MASH P3 trial will be started in Q3/2027, approved in 2029, and reach $2B to $3B peak sales in 2031-2032, which will contribute $8B to $15B to MC.
Let's do the match:
- MC low = (4+8+4+8) $24B, or $SP low = $240;
- MC high = (5+10+5+15) $35B, or SP high = $350.
Cheers and GLTA!
$SP https://www.youtube.com/watch?v=tonxxchU9No&t=190s Wow, our POTUS Trump did so many insider trading (via someone who was doing these trades for him) that no wonder he's not taking any salary. It's hypocrisy to convict anyone for doing "insider trading" when POTUS is the biggest Insider of them all. Everyone said he was doing this but I did not know he was doing this much insider trading.
